UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy of Voclosporin in Proliferative Lupus Nephritis with High Levels of Proteinuria

Clinical journal of the American Society of Nephrology, 2024-03, Vol.19 (3), p.309-318

2024

Volltextzugriff (PDF)

Soluble and membrane-bound TGF-β-mediated regulation of intratumoral T cell differentiation and function in B-cell non-Hodgkin lymphoma

PloS one, 2013-03, Vol.8 (3), p.e59456

2013

Volltextzugriff (PDF)

Multidisciplinary model to implement pharmacogenomics at the point of care

Genetics in medicine, 2017-04, Vol.19 (4), p.421-429

2017

Volltextzugriff (PDF)

Prognostic Significance of Pretreatment Serum Cytokines in Classical Hodgkin Lymphoma

Clinical cancer research, 2013-12, Vol.19 (24), p.6812-6819

2013

Volltextzugriff (PDF)

Comprehensive analysis of tumor microenvironment cytokines in Waldenstrom macroglobulinemia identifies CCL5 as a novel modulator of IL-6 activity

Blood, 2011-11, Vol.118 (20), p.5540-5549

2011

Volltextzugriff (PDF)

1007 Voclosporin for lupus nephritis: assessment of long-term safety and efficacy including renal outcome over three years of treatment in the phase 3 AURORA 1 and AURORA 2 studies

Lupus science & medicine, 2024-05, Vol.11 (Suppl 2), p.A85-A85

2024

Volltextzugriff (PDF)

IL-21 in the bone marrow microenvironment contributes to IgM secretion and proliferation of malignant cells in Waldenstrom macroglobulinemia

Blood, 2012-11, Vol.120 (18), p.3774-3782

2012

Volltextzugriff (PDF)

P87 Comparison of a voclosporin-based, triple immunotherapy regimen to high-dose glucocorticoid-based immunosuppressive therapy: a propensity analysis of the AURA-LV plus AURORA 1 studies and ALMS

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A104-A105

2024

Volltextzugriff (PDF)

Alterations in drug disposition during pregnancy: implications for drug therapy

Expert opinion on drug metabolism & toxicology, 2007-08, Vol.3 (4), p.557-571

2007

Volltextzugriff (PDF)

Establishment and characterization of a novel Waldenström macroglobulinemia cell line, MWCL-1

Blood, 2011-05, Vol.117 (19), p.e190-e197

2011

Volltextzugriff (PDF)

Constitutive activation of STAT5A and STAT5B regulates IgM secretion in Waldenström's macroglobulinemia

Blood, 2014-02, Vol.123 (7), p.1055-1058

2014

Volltextzugriff (PDF)

Molecular pathogenesis of Waldenström’s macroglobulinemia

Haematologica (Roma), 2012-09, Vol.97 (9), p.1281-1290

2012

Volltextzugriff (PDF)

The deaminated metabolite of gemcitabine, 2',2'-difluorodeoxyuridine, modulates the rate of gemcitabine transport and intracellular phosphorylation via deoxycytidine kinase

Drug metabolism and disposition, 2011-11, Vol.39 (11), p.2013-2016

2011

Volltextzugriff (PDF)

Waldenström’s macroglobulinemia: Treatment approaches for newly diagnosed and relapsed disease

Transfusion and apheresis science, 2013-08, Vol.49 (1), p.19-23

2013

Volltextzugriff (PDF)

Localized delivery of chemotherapy to the cervix for radiosensitization

Gynecologic oncology, 2012-10, Vol.127 (1), p.121-125

2012

Volltextzugriff (PDF)

B-cell activating factor-receptor specific activation of tumor necrosis factor receptor associated factor 6 and the phosphatidyl inositol 3-kinase pathway in lymphoma B cells

Leukemia & lymphoma, 2014-08, Vol.55 (8), p.1884-1892

2014

Volltextzugriff (PDF)

Long-Term Safety and Efficacy of Voclosporin in Black Patients with Lupus Nephritis: SA-PO876

Journal of the American Society of Nephrology, 2023-11, Vol.34 (11S), p.971-971

2023

Volltextzugriff (PDF)

3032 EFFICACY AND SAFETY OF VOCLOSPORIN IN PATIENTS WITH PROTEINURIA ≥2 MG/MG: AN INTEGRATED ANALYSIS OF THE AURA-LV AND AURORA 1 STUDIES

Nephrology, dialysis, transplantation, 2023-06, Vol.38 (Supplement_1)

2023

Volltextzugriff (PDF)

Jak/Stat Pathway in Waldenström's Macroglobulinemia

Clinical lymphoma, myeloma and leukemia, 2011-02, Vol.11 (1), p.112-114

2011

Volltextzugriff (PDF)

FC056: Early Reductions in Proteinuria with Voclosporin Treatment Across Lupus Nephritis Biopsy Classes: Pooled Data from the AURA-LV AND AURORA 1 Trials

Nephrology, dialysis, transplantation, 2022-05, Vol.37 (Supplement_3)

2022

Volltextzugriff (PDF)

Disease Targeting Properties of Voclosporin in Kidney Transplant and Lupus Nephritis Patients: TH-PO642

Journal of the American Society of Nephrology, 2024-10, Vol.35 (10S)

2024

Volltextzugriff (PDF)

468 Voclosporin-based, triple-immunosuppressive therapy vs high-dose glucocorticoid-based dual-immunotherapy for lupus nephritis: a propensity analysis

Nephrology, dialysis, transplantation, 2024-05, Vol.39 (Supplement_1)

2024

Volltextzugriff (PDF)

Comparison of Dual-Immunosuppressive Therapy and a Voclosporin-Based, Triple-Immunosuppressive Regimen for Lupus Nephritis: A Propensity Analysis of ALMS and AURORA 1: SA-PO877

Journal of the American Society of Nephrology, 2023-11, Vol.34 (11S), p.971-971

2023

Volltextzugriff (PDF)

Enlight-LN Registry: Baseline Demographics and Clinical Characteristics of an Initial Cohort of Patients Treated with Voclosporin for Lupus Nephritis in the United States: TH-PO653

Journal of the American Society of Nephrology, 2024-10, Vol.35 (10S)

2024

Volltextzugriff (PDF)

Voclosporin for Lupus Nephritis: Assessment of Long-Term Safety and Efficacy Including Renal Outcome Over 3 Years of Treatment in the Phase 3 AURORA 1 and AURORA 2 Studies: TH-PO486

Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.184-184

2022

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(52)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(62)

Erscheinungsjahr

n.n

Thema

Science & Technology
(27)
Humans
(24)
Life Sciences & Biomedicine
(23)
Hematology
(12)
Female
(8)
Male
(8)
Biological And Medical Sciences
(6)
Medical Sciences
(6)
Oncology
(6)
Adult
(5)
Aged
(5)
Cell Line, Tumor
(4)
Hematologic And Hematopoietic Diseases
(4)
Hematology, Oncology And Palliative Medicine
(4)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(4)
Quality Of Life
(4)
Signal Transduction
(4)
Waldenstrom Macroglobulinemia - Pathology
(4)
Aged, 80 And Over
(3)
Biopsy
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Efficacy of Voclosporin in Proliferative Lupus Nephritis with High Levels of Proteinuria

Soluble and membrane-bound TGF-β-mediated regulation of intratumoral T cell differentiation and function in B-cell non-Hodgkin lymphoma

Multidisciplinary model to implement pharmacogenomics at the point of care

Prognostic Significance of Pretreatment Serum Cytokines in Classical Hodgkin Lymphoma

Comprehensive analysis of tumor microenvironment cytokines in Waldenstrom macroglobulinemia identifies CCL5 as a novel modulator of IL-6 activity

1007 Voclosporin for lupus nephritis: assessment of long-term safety and efficacy including renal outcome over three years of treatment in the phase 3 AURORA 1 and AURORA 2 studies

IL-21 in the bone marrow microenvironment contributes to IgM secretion and proliferation of malignant cells in Waldenstrom macroglobulinemia

P87 Comparison of a voclosporin-based, triple immunotherapy regimen to high-dose glucocorticoid-based immunosuppressive therapy: a propensity analysis of the AURA-LV plus AURORA 1 studies and ALMS

Alterations in drug disposition during pregnancy: implications for drug therapy

Establishment and characterization of a novel Waldenström macroglobulinemia cell line, MWCL-1

Constitutive activation of STAT5A and STAT5B regulates IgM secretion in Waldenström's macroglobulinemia

Molecular pathogenesis of Waldenström’s macroglobulinemia

The deaminated metabolite of gemcitabine, 2',2'-difluorodeoxyuridine, modulates the rate of gemcitabine transport and intracellular phosphorylation via deoxycytidine kinase

Waldenström’s macroglobulinemia: Treatment approaches for newly diagnosed and relapsed disease

Localized delivery of chemotherapy to the cervix for radiosensitization

B-cell activating factor-receptor specific activation of tumor necrosis factor receptor associated factor 6 and the phosphatidyl inositol 3-kinase pathway in lymphoma B cells

Long-Term Safety and Efficacy of Voclosporin in Black Patients with Lupus Nephritis: SA-PO876

3032 EFFICACY AND SAFETY OF VOCLOSPORIN IN PATIENTS WITH PROTEINURIA ≥2 MG/MG: AN INTEGRATED ANALYSIS OF THE AURA-LV AND AURORA 1 STUDIES

Jak/Stat Pathway in Waldenström's Macroglobulinemia

FC056: Early Reductions in Proteinuria with Voclosporin Treatment Across Lupus Nephritis Biopsy Classes: Pooled Data from the AURA-LV AND AURORA 1 Trials

Disease Targeting Properties of Voclosporin in Kidney Transplant and Lupus Nephritis Patients: TH-PO642

468 Voclosporin-based, triple-immunosuppressive therapy vs high-dose glucocorticoid-based dual-immunotherapy for lupus nephritis: a propensity analysis

Comparison of Dual-Immunosuppressive Therapy and a Voclosporin-Based, Triple-Immunosuppressive Regimen for Lupus Nephritis: A Propensity Analysis of ALMS and AURORA 1: SA-PO877

Enlight-LN Registry: Baseline Demographics and Clinical Characteristics of an Initial Cohort of Patients Treated with Voclosporin for Lupus Nephritis in the United States: TH-PO653

Voclosporin for Lupus Nephritis: Assessment of Long-Term Safety and Efficacy Including Renal Outcome Over 3 Years of Treatment in the Phase 3 AURORA 1 and AURORA 2 Studies: TH-PO486

Suchergebnisse filtern